Eugene Marcantonio
Amministratore Delegato presso ARMGO Pharma, Inc.
Posizioni attive di Eugene Marcantonio
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
ARMGO Pharma, Inc.
 ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | Direttore/Membro del Consiglio | 01/10/2017 | - |
| Amministratore Delegato | 01/01/2021 | - | |
| Direttore Tecnico/Scientifico/R&S | 01/04/2017 | 01/01/2021 | |
| Presidente | 01/04/2017 | 01/01/2021 |
Storia della carriera di Eugene Marcantonio
Formazione di Eugene Marcantonio
| New York University School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
ARMGO Pharma, Inc.
ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Eugene Marcantonio
- Esperienza
